Exact Mass: 438.0613

Exact Mass Matches: 438.0613

Found 27 metabolites which its exact mass value is equals to given mass value 438.0613, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Remimazolam

methyl 3-[(7S)-12-bromo-3-methyl-9-(pyridin-2-yl)-2,5,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,8,10,12-hexaen-7-yl]propanoate

C21H19BrN4O2 (438.0691)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   
   
   

Bartramic acid

Bartramic acid

C22H14O10 (438.0587)


   
   

Met-Phe4Cl-OH

(S)-3-(4-chlorophenyl)-2-(3-(2-(methylthio)ethoxy)-4-nitrobenzamido)propanoic acid

C19H19ClN2O6S (438.0652)


   

Phe4Cl-Met-OH

(S)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)-5-(methylthio)pentanoic acid

C19H19ClN2O6S (438.0652)


   

n-(8-maleimidocapryloxy)sulfosuccinimide, sodium salt

n-(8-maleimidocapryloxy)sulfosuccinimide, sodium salt

C16H19N2NaO9S (438.0709)


   

2,6-Dichloro-3-(tributylstannyl)pyrazine

2,6-Dichloro-3-(tributylstannyl)pyrazine

C16H28Cl2N2Sn (438.0651)


   

5-(2,4-difluorophenyl)-2-hydroxy-N-[4-nitro-3-(trifluoromethyl)phenyl]benzamide

5-(2,4-difluorophenyl)-2-hydroxy-N-[4-nitro-3-(trifluoromethyl)phenyl]benzamide

C20H11F5N2O4 (438.0639)


   

Calconcarboxylic acid

Calconcarboxylic acid

C21H14N2O7S (438.0522)


   

6-Methyl-Thiamin Diphosphate

6-Methyl-Thiamin Diphosphate

C13H20N4O7P2S (438.0528)


   

CNS-7056

Remimazolam

C21H19BrN4O2 (438.0691)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

3-[4-[(4,6-Dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methyl]-3-(2-oxo-1-benzopyran-3-yl)-1-pyrazolyl]propanoic acid

3-[4-[(4,6-Dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methyl]-3-(2-oxo-1-benzopyran-3-yl)-1-pyrazolyl]propanoic acid

C20H14N4O6S (438.0634)


   

3-Methoxybenzylglucosinolate

3-Methoxybenzylglucosinolate

C15H20NO10S2- (438.0529)


   

1-(4-Bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane

1-(4-Bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane

C19H23BrN2O3S (438.0613)


   

3-[4-[(E)-3-(4-Bromophenyl)-3-oxoprop-1-enyl]-3-(4-methylphenyl)pyrazol-1-yl]propanoic acid

3-[4-[(E)-3-(4-Bromophenyl)-3-oxoprop-1-enyl]-3-(4-methylphenyl)pyrazol-1-yl]propanoic acid

C22H19BrN2O3 (438.0579)


   

(2R)-2-hydroxy-3,3-dimethyl-1-oxo-1-[[3-oxo-3-(2-sulfosulfanylethylamino)propyl]amino]-4-phosphonooxybutane

(2R)-2-hydroxy-3,3-dimethyl-1-oxo-1-[[3-oxo-3-(2-sulfosulfanylethylamino)propyl]amino]-4-phosphonooxybutane

C11H23N2O10PS2 (438.0532)


   

glucolimnanthin(1-)

glucolimnanthin(1-)

C15H20NO10S2 (438.0529)


An aralkylglucosinolate that is glucotropeolin in which the phenyl group is substituted at position 3 by a methoxy group.

   

2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-en-1-yl)benzaldehyde

2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-en-1-yl)benzaldehyde

C21H20Cl2O6 (438.0637)


   

(1r,4s,5r,6r,7s,9r,11r,14s,15r,16r,19r)-5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

(1r,4s,5r,6r,7s,9r,11r,14s,15r,16r,19r)-5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)


   

5,15,16-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docos-6-ene-2,8,12,18-tetrone

5,15,16-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docos-6-ene-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)


   

2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-3,4-dihydroxybenzoic acid

2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-3,4-dihydroxybenzoic acid

C22H14O10 (438.0587)


   

(4s,5s,9s,14s,15r,16s,19r)-5,15,16-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docos-6-ene-2,8,12,18-tetrone

(4s,5s,9s,14s,15r,16s,19r)-5,15,16-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docos-6-ene-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)


   

5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)


   

(1s,4r,5s,6s,7r,9s,11s,14r,15s,16s,19s)-5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

(1s,4r,5s,6s,7r,9s,11s,14r,15s,16s,19s)-5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)